{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:12:41Z","timestamp":1793311961968,"version":"4.5.0"},"reference-count":308,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00210-023-02804-y","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T10:02:13Z","timestamp":1700042533000},"page":"2651-2679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Therapeutic management of ischemic stroke"],"prefix":"10.1007","volume":"397","author":[{"given":"Priya","family":"Bindal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshay","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"issue":"2","key":"2804_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1517\/17425255.2012.652615","volume":"8","author":"P Acheampong","year":"2012","unstructured":"Acheampong P, Ford GA (2012) Pharmacokinetics of alteplase in the treatment of ischaemic stroke. Expert Opin Drug Metab Toxicol 8(2):271\u2013281","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"2804_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.0022-3042.2001.00697.x","volume":"80","author":"RM Adibhatla","year":"2002","unstructured":"Adibhatla RM, Hatcher J, Dempsey R (2002) Citicoline: neuroprotective mechanisms in cerebral ischemia. J Neurochem 80(1):12\u201323","journal-title":"J Neurochem"},{"issue":"1","key":"2804_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-012-1335-6","volume":"367","author":"A Ahmad","year":"2012","unstructured":"Ahmad A et al (2012) Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat. Mol Cell Biochem 367(1):215\u2013225","journal-title":"Mol Cell Biochem"},{"key":"2804_CR4","doi-asserted-by":"crossref","unstructured":"Al Kasab S, Spiotta AM (2021) Direct aspiration thrombectomy for acute stroke: evolution of technique and evidence.\u00a0In: 12 Strokes: A case-based guide to acute ischemic stroke management. pp 113\u2013128","DOI":"10.1007\/978-3-030-56857-3_8"},{"issue":"1","key":"2804_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.STR.0000106763.46123.F6","volume":"35","author":"MJ Alberts","year":"2004","unstructured":"Alberts MJ et al (2004) Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 35(1):175\u2013178","journal-title":"Stroke"},{"key":"2804_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2019.02.025","volume":"142","author":"M Albrecht","year":"2019","unstructured":"Albrecht M et al (2019) Neuroprotective strategies following perinatal hypoxia-ischemia: taking aim at NOS. Free Radical Biol Med 142:123\u2013131","journal-title":"Free Radical Biol Med"},{"issue":"3","key":"2804_CR7","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S2214-109X(17)30058-X","volume":"5","author":"L Allen","year":"2017","unstructured":"Allen L et al (2017) Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Glob Health 5(3):e277\u2013e289","journal-title":"Lancet Glob Health"},{"issue":"3","key":"2804_CR8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/brainsci3031395","volume":"3","author":"J \u00c1lvarez-Sab\u00edn","year":"2013","unstructured":"\u00c1lvarez-Sab\u00edn J, Rom\u00e1n GC (2013) The role of citicoline in neuroprotection and neurorepair in ischemic stroke. Brain Sci 3(3):1395\u20131414","journal-title":"Brain Sci"},{"issue":"3","key":"2804_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.resuscitation.2006.01.017","volume":"70","author":"AG Alzaga","year":"2006","unstructured":"Alzaga AG, Cerdan M, Varon J (2006) Therapeutic hypothermia. Resuscitation 70(3):369\u2013380","journal-title":"Resuscitation"},{"key":"2804_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuropharm.2017.09.021","volume":"134","author":"AP Amar","year":"2018","unstructured":"Amar AP et al (2018) Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. Neuropharmacology 134:293\u2013301","journal-title":"Neuropharmacology"},{"issue":"1","key":"2804_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13012-018-0842-6","volume":"14","author":"NE Andrew","year":"2019","unstructured":"Andrew NE et al (2019) Hospital organizational context and delivery of evidence-based stroke care: a cross-sectional study. Implement Sci 14(1):1\u201312","journal-title":"Implement Sci"},{"issue":"3","key":"2804_CR12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/157340310791658802","volume":"6","author":"M Angels Font","year":"2010","unstructured":"Angels Font M, Arboix A, Krupinski J (2010) Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev 6(3):238\u2013244","journal-title":"Curr Cardiol Rev"},{"key":"2804_CR13","doi-asserted-by":"crossref","unstructured":"Arens EA, Zhang H (2006) The skin\u2019s role in human thermoregulation and comfort","DOI":"10.1201\/9781439824351.ch16"},{"issue":"9601","key":"2804_CR14","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","volume":"370","author":"J Armitage","year":"2007","unstructured":"Armitage J (2007) The safety of statins in clinical practice. Lancet 370(9601):1781\u20131790","journal-title":"Lancet"},{"issue":"6","key":"2804_CR15","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1007\/s12035-016-0019-8","volume":"54","author":"MC Arthur","year":"2017","unstructured":"Arthur MC et al (2017) Dodecafluoropentane improves neurological function following anterior ischemic stroke. Mol Neurobiol 54(6):4764\u20134770","journal-title":"Mol Neurobiol"},{"issue":"8","key":"2804_CR16","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/imj.12652","volume":"45","author":"H Asadi","year":"2015","unstructured":"Asadi H et al (2015) Advances in endovascular treatment of acute ischaemic stroke. Intern Med J 45(8):798\u2013805","journal-title":"Intern Med J"},{"issue":"9411","key":"2804_CR17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","volume":"363","author":"ATLANTIS, T","year":"2004","unstructured":"ATLANTIS, T (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363(9411):768\u2013774","journal-title":"Lancet"},{"issue":"1","key":"2804_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1397-3","volume":"17","author":"A Avan","year":"2019","unstructured":"Avan A et al (2019) Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Med 17(1):1\u201330","journal-title":"BMC Med"},{"issue":"5","key":"2804_CR19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10557-019-06904-x","volume":"33","author":"V Azemawah","year":"2019","unstructured":"Azemawah V et al (2019) State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications. Cardiovasc Drugs Ther 33(5):625\u2013639","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"2804_CR20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12296","volume":"276","author":"L Badimon","year":"2014","unstructured":"Badimon L, Vilahur G (2014) Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 276(6):618\u2013632","journal-title":"J Intern Med"},{"key":"2804_CR21","doi-asserted-by":"publisher","unstructured":"Baird AE, Jackson R, Jin W (2021) Tenecteplase for acute ischemic stroke treatment. Semin Neurol 41(1):28\u201338.\u00a0https:\/\/doi.org\/10.1055\/s-0040-1722722","DOI":"10.1055\/s-0040-1722722"},{"issue":"4","key":"2804_CR22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccr.2008.08.012","volume":"14","author":"K Bajou","year":"2008","unstructured":"Bajou K et al (2008) Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 14(4):324\u2013334","journal-title":"Cancer Cell"},{"issue":"8","key":"2804_CR23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/ijs.12618","volume":"10","author":"JS Balami","year":"2015","unstructured":"Balami JS et al (2015) A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke. Int J Stroke 10(8):1168\u20131178","journal-title":"Int J Stroke"},{"issue":"2","key":"2804_CR24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5853\/jos.2015.17.2.127","volume":"17","author":"A Balasubramaian","year":"2015","unstructured":"Balasubramaian A et al (2015) Evolution of endovascular therapy in acute stroke: implications of device development. J Stroke 17(2):127","journal-title":"J Stroke"},{"key":"2804_CR25","doi-asserted-by":"crossref","first-page":"118575","DOI":"10.1016\/j.lfs.2020.118575","volume":"263","author":"AH Barfejani","year":"2020","unstructured":"Barfejani AH et al (2020) Donepezil in the treatment of ischemic stroke: review and future perspective. Life Sci 263:118575","journal-title":"Life Sci"},{"issue":"4","key":"2804_CR26","doi-asserted-by":"crossref","first-page":"165260","DOI":"10.1016\/j.bbadis.2018.09.012","volume":"1866","author":"D Barthels","year":"2020","unstructured":"Barthels D, Das H (2020) Current advances in ischemic stroke research and therapies. Biochim Biophys Acta (BBA)-Mol Basis Dis 1866(4):165260","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"6","key":"2804_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-013-0333-9","volume":"15","author":"N Beadell","year":"2013","unstructured":"Beadell N, Lutsep H (2013) New stent retriever devices. Curr Atheroscler Rep 15(6):1\u20136","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"2804_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488609789006949","volume":"4","author":"J Beltowski","year":"2009","unstructured":"Beltowski J, Wojcicka G, Jamroz-Wisniewska A (2009) Adverse effects of statins-mechanisms and consequences. Curr Drug Saf 4(3):209\u2013228","journal-title":"Curr Drug Saf"},{"key":"2804_CR29","doi-asserted-by":"crossref","unstructured":"Bereczki D, Fekete I (2008) Vinpocetine for acute ischaemic stroke. Cochrane Database Syst Rev\u00a02008(1):2\u201317","DOI":"10.1002\/14651858.CD000480.pub2"},{"issue":"2","key":"2804_CR30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0173(99)00009-0","volume":"30","author":"R Berger","year":"1999","unstructured":"Berger R, Garnier Y (1999) Pathophysiology of perinatal brain damage. Brain Res Rev 30(2):107\u2013134","journal-title":"Brain Res Rev"},{"issue":"9","key":"2804_CR31","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/biom11091316","volume":"11","author":"R Berlet","year":"2021","unstructured":"Berlet R et al (2021) Combination of stem cells and rehabilitation therapies for ischemic stroke. Biomolecules 11(9):1316","journal-title":"Biomolecules"},{"issue":"6","key":"2804_CR32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/life11060482","volume":"11","author":"S Bernardo-Castro","year":"2021","unstructured":"Bernardo-Castro S et al (2021) Therapeutic nanoparticles for the different phases of ischemic stroke. Life 11(6):482","journal-title":"Life"},{"issue":"1","key":"2804_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrd985","volume":"2","author":"DL Bhatt","year":"2003","unstructured":"Bhatt DL, Topol EJ (2003) Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discovery 2(1):15\u201328","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"2804_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1276-z","volume":"10","author":"X Bian","year":"2019","unstructured":"Bian X et al (2019) Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases. Stem Cell Res Ther 10(1):1\u201318","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"2804_CR35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5853\/jos.2013.15.2.90","volume":"15","author":"A Bivard","year":"2013","unstructured":"Bivard A, Lin L, Parsonsb MW (2013) Review of stroke thrombolytics. J Stroke 15(2):90\u201398","journal-title":"J Stroke"},{"issue":"1\u20132","key":"2804_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2007.04.031","volume":"261","author":"JO Blakeley","year":"2007","unstructured":"Blakeley JO, Llinas RH (2007) Thrombolytic therapy for acute ischemic stroke. J Neurol Sci 261(1\u20132):55\u201362","journal-title":"J Neurol Sci"},{"issue":"1","key":"2804_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0913-2","volume":"9","author":"AC Boese","year":"2018","unstructured":"Boese AC et al (2018) Neural stem cell therapy for subacute and chronic ischemic stroke. Stem Cell Res Ther 9(1):1\u201317","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"2804_CR38","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3174\/ajnr.A1110","volume":"29","author":"A Bose","year":"2008","unstructured":"Bose A et al (2008) The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. Am J Neuroradiol 29(7):1409\u20131413","journal-title":"Am J Neuroradiol"},{"issue":"9","key":"2804_CR39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrneurol.2009.116","volume":"5","author":"M Bouckaert","year":"2009","unstructured":"Bouckaert M, Lemmens R, Thijs V (2009) Reducing prehospital delay in acute stroke. Nat Rev Neurol 5(9):477\u2013483","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2804_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-9276-4-2","volume":"4","author":"A Boutayeb","year":"2005","unstructured":"Boutayeb A, Boutayeb S (2005) The burden of non communicable diseases in developing countries. Int J Equity Health 4(1):1\u20138","journal-title":"Int J Equity Health"},{"key":"2804_CR41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jth.12247","volume":"11","author":"E Bouwens","year":"2013","unstructured":"Bouwens E, Stavenuiter F, Mosnier L (2013) Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway. J Thromb Haemost 11:242\u2013253","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2804_CR42","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.arth.2009.06.021","volume":"25","author":"KJ Bozic","year":"2010","unstructured":"Bozic KJ et al (2010) Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty 25(7):1053\u20131060","journal-title":"J Arthroplasty"},{"issue":"11","key":"2804_CR43","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S1474-4422(16)30177-6","volume":"15","author":"S Bracard","year":"2016","unstructured":"Bracard S et al (2016) Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. The Lancet Neurology 15(11):1138\u20131147","journal-title":"The Lancet Neurology"},{"issue":"6","key":"2804_CR44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","volume":"63","author":"M Brault","year":"2014","unstructured":"Brault M et al (2014) Statin treatment and new-onset diabetes: a review of proposed mechanisms. Metabolism 63(6):735\u2013745","journal-title":"Metabolism"},{"issue":"4","key":"2804_CR45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2011.03.002","volume":"25","author":"K Broos","year":"2011","unstructured":"Broos K et al (2011) Platelets at work in primary hemostasis. Blood Rev 25(4):155\u2013167","journal-title":"Blood Rev"},{"key":"2804_CR46","first-page":"107","volume":"5","author":"PY Cai","year":"2014","unstructured":"Cai PY et al (2014) Vagus nerve stimulation in ischemic stroke: old wine in a new bottle. Front Neurol 5:107","journal-title":"Front Neurol"},{"key":"2804_CR47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biochi.2020.09.025","volume":"179","author":"Y Cai","year":"2020","unstructured":"Cai Y et al (2020) Stroke treatment: is exosome therapy superior to stem cell therapy? Biochimie 179:190\u2013204","journal-title":"Biochimie"},{"issue":"8","key":"2804_CR48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S1474-4422(15)00140-4","volume":"14","author":"BC Campbell","year":"2015","unstructured":"Campbell BC et al (2015) Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol 14(8):846\u2013854","journal-title":"Lancet Neurol"},{"issue":"1","key":"2804_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0118-8","volume":"5","author":"BC Campbell","year":"2019","unstructured":"Campbell BC et al (2019) Ischaemic stroke. Nat Rev Dis Primers 5(1):1\u201322","journal-title":"Nat Rev Dis Primers"},{"issue":"13","key":"2804_CR50","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jama.2020.1511","volume":"323","author":"BC Campbell","year":"2020","unstructured":"Campbell BC et al (2020) Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial. JAMA 323(13):1257\u20131265","journal-title":"JAMA"},{"issue":"18","key":"2804_CR51","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1021\/jm0603670","volume":"49","author":"S Chackalamannil","year":"2006","unstructured":"Chackalamannil S (2006) Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects. J Med Chem 49(18):5389\u20135403","journal-title":"J Med Chem"},{"issue":"4\u20136","key":"2804_CR52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.vph.2007.12.004","volume":"48","author":"S Chakrabarti","year":"2008","unstructured":"Chakrabarti S, Freedman JE (2008) Dipyridamole, cerebrovascular disease, and the vasculature. Vascul Pharmacol 48(4\u20136):143\u2013149","journal-title":"Vascul Pharmacol"},{"issue":"8","key":"2804_CR53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","volume":"15","author":"\u00c1 Chamorro","year":"2016","unstructured":"Chamorro \u00c1 et al (2016) Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol 15(8):869\u2013881","journal-title":"Lancet Neurol"},{"key":"2804_CR54","first-page":"75","volume":"10","author":"SN Chapman","year":"2014","unstructured":"Chapman SN et al (2014) Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag 10:75","journal-title":"Vasc Health Risk Manag"},{"key":"2804_CR55","doi-asserted-by":"crossref","unstructured":"Chartrain AG, Awad AJ, Mocco J (2018) Principles for complication avoidance and management in thrombectomy for ischemic stroke. In: Cerebrovascular and endovascular neurosurgery: Complication avoidance and management, pp 375\u2013396","DOI":"10.1007\/978-3-319-65206-1_30"},{"issue":"6","key":"2804_CR56","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.10555","volume":"53","author":"J Chen","year":"2003","unstructured":"Chen J et al (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53(6):743\u2013751","journal-title":"Ann Neurol"},{"issue":"7","key":"2804_CR57","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/jcbfm.2010.19","volume":"30","author":"Z-B Chen","year":"2010","unstructured":"Chen Z-B et al (2010) Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-\u03baB. J Cereb Blood Flow Metab 30(7):1356\u20131365","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"2804_CR58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0959-4388(96)80101-2","volume":"6","author":"DW Choi","year":"1996","unstructured":"Choi DW (1996) Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6(5):667\u2013672","journal-title":"Curr Opin Neurobiol"},{"issue":"7329","key":"2804_CR59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"AT Collaboration","year":"2002","unstructured":"Collaboration AT (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71\u201386","journal-title":"BMJ"},{"issue":"04","key":"2804_CR60","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1160\/TH04-11-0724","volume":"93","author":"D Collen","year":"2005","unstructured":"Collen D, Lijnen RH (2005) Thrombolytic agents. Thromb Haemost 93(04):627\u2013630","journal-title":"Thromb Haemost"},{"issue":"1","key":"2804_CR61","first-page":"25","volume":"43","author":"MP Cruz","year":"2018","unstructured":"Cruz MP (2018) Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis. Pharmacy Ther 43(1):25","journal-title":"Pharmacy Ther"},{"issue":"1","key":"2804_CR62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ana.25493","volume":"86","author":"LL Cui","year":"2019","unstructured":"Cui LL et al (2019) Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Ann Neurol 86(1):5\u201316","journal-title":"Ann Neurol"},{"issue":"5","key":"2804_CR63","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ihj.2013.08.032","volume":"65","author":"J Dalal","year":"2013","unstructured":"Dalal J et al (2013) Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenario. Indian Heart J 65(5):566\u2013585","journal-title":"Indian Heart J"},{"issue":"3","key":"2804_CR64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2005.11.013","volume":"119","author":"JE Dalen","year":"2006","unstructured":"Dalen JE (2006) Aspirin to prevent heart attack and stroke: what\u2019s the right dose? Am J Med 119(3):198\u2013202","journal-title":"Am J Med"},{"issue":"28","key":"2804_CR65","first-page":"2677","volume":"8","author":"R Darwazeh","year":"2013","unstructured":"Darwazeh R, Yan Y (2013) Mild hypothermia as a treatment for central nervous system injuries: positive or negative effects. Neural Regen Res 8(28):2677","journal-title":"Neural Regen Res"},{"key":"2804_CR66","doi-asserted-by":"crossref","unstructured":"Das D, Goyal A (2014) Pharmaceutical enzymes, in Biotransformation of waste biomass into high value biochemicals, Springer, p. 367-387","DOI":"10.1007\/978-1-4614-8005-1_15"},{"issue":"7","key":"2804_CR67","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0149-2918(01)80086-2","volume":"23","author":"L Davydov","year":"2001","unstructured":"Davydov L, Cheng JW (2001) Tenecteplase: a review. Clin Ther 23(7):982\u2013997","journal-title":"Clin Ther"},{"issue":"10284","key":"2804_CR68","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(21)00475-X","volume":"397","author":"J Dawson","year":"2021","unstructured":"Dawson J et al (2021) Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. The Lancet 397(10284):1545\u20131553","journal-title":"The Lancet"},{"key":"2804_CR69","volume":"175","author":"PEM de Castilla","year":"2021","unstructured":"de Castilla PEM et al (2021) Extracellular vesicles as a drug delivery system: a systematic review of preclinical studies. Adv Drug Deliv Rev 175:113801","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"2804_CR70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2006.03.022","volume":"247","author":"MA de Leci\u00f1ana","year":"2006","unstructured":"de Leci\u00f1ana MA et al (2006) Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J Neurol Sci 247(2):121\u2013129","journal-title":"J Neurol Sci"},{"key":"2804_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-015-1178-0","volume":"20","author":"AL de Oliveira Manoel","year":"2016","unstructured":"de Oliveira Manoel AL et al (2016) The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care 20:1\u201329","journal-title":"Crit Care"},{"issue":"1","key":"2804_CR72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/brainsci3010191","volume":"3","author":"FG De Cerio","year":"2013","unstructured":"De Cerio FG et al (2013) Neuroprotective therapies after perinatal hypoxic-ischemic brain injury. Brain Sci 3(1):191\u2013214","journal-title":"Brain Sci"},{"issue":"4","key":"2804_CR73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/HTR.0b013e318217df55","volume":"27","author":"A Demirtas-Tatlidede","year":"2012","unstructured":"Demirtas-Tatlidede A et al (2012) Noninvasive brain stimulation in traumatic brain injury. J Head Trauma Rehabil 27(4):274","journal-title":"J Head Trauma Rehabil"},{"issue":"3","key":"2804_CR74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00210-007-0141-2","volume":"375","author":"R Di Paola","year":"2007","unstructured":"Di Paola R, Cuzzocrea S (2007) Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 375(3):157\u2013175","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2804_CR75","doi-asserted-by":"crossref","unstructured":"De Diego AM et al (2012) Multitarget drugs for stabilization of calcium cycling and neuroprotection in neurodegenerative diseases and stroke. Therapeutic Targets: Modulation, Inhibition and Activation eds L. Botana, M. Loza (Hoboken, NJ: Wiley and Sons Inc.), p. 123\u2013200","DOI":"10.1002\/9781118185537.ch4"},{"issue":"4","key":"2804_CR76","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/01616412.2020.1711648","volume":"42","author":"Y Dong","year":"2020","unstructured":"Dong Y et al (2020) Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial. Neurol Res 42(4):286\u2013290","journal-title":"Neurol Res"},{"key":"2804_CR77","unstructured":"Donkor ES (2018) Stroke in the century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat 2018"},{"key":"2804_CR78","unstructured":"Dubey A et al (2020) Review on Vinpocetine. Int J Pharm Life Sci 11(5):1\u20138"},{"issue":"13","key":"2804_CR79","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.micinf.2009.08.013","volume":"11","author":"L Duprez","year":"2009","unstructured":"Duprez L et al (2009) Major cell death pathways at a glance. Microbes Infect 11(13):1050\u20131062","journal-title":"Microbes Infect"},{"issue":"9","key":"2804_CR80","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.jcbfm.9600116","volume":"25","author":"M Endres","year":"2005","unstructured":"Endres M (2005) Statins and stroke. J Cereb Blood Flow Metab 25(9):1093\u20131110","journal-title":"J Cereb Blood Flow Metab"},{"key":"2804_CR81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fnins.2019.00280","volume":"13","author":"ND Engineer","year":"2019","unstructured":"Engineer ND et al (2019) Targeted vagus nerve stimulation for rehabilitation after stroke. Front Neurosci 13:280","journal-title":"Front Neurosci"},{"issue":"3","key":"2804_CR82","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-5223(94)70334-5","volume":"107","author":"MA Ergin","year":"1994","unstructured":"Ergin MA et al (1994) Hypothermic circulatory arrest in operations on the thoracic aorta: determinants of operative mortality and neurologic outcome. J Thorac Cardiovasc Surg 107(3):788\u2013799","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2804_CR83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pathophys.2017.07.001","volume":"24","author":"RS Eshaq","year":"2017","unstructured":"Eshaq RS et al (2017) Diabetic retinopathy: breaking the barrier. Pathophysiology 24(4):229\u2013241","journal-title":"Pathophysiology"},{"issue":"597","key":"2804_CR84","doi-asserted-by":"crossref","first-page":"eabb6716","DOI":"10.1126\/scitranslmed.abb6716","volume":"13","author":"Z Fang","year":"2021","unstructured":"Fang Z et al (2021) An MD2-perturbing peptide has therapeutic effects in rodent and rhesus monkey models of stroke. Sci Transl Med 13(597):eabb6716","journal-title":"Sci Transl Med"},{"issue":"9913","key":"2804_CR85","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","volume":"383","author":"VL Feigin","year":"2014","unstructured":"Feigin VL et al (2014) Global and regional burden of stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010. The Lancet 383(9913):245\u2013255","journal-title":"The Lancet"},{"issue":"2","key":"2804_CR86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12028-007-0068-y","volume":"7","author":"AC Flint","year":"2007","unstructured":"Flint AC, Hemphill JC, Bonovich DC (2007) Therapeutic hypothermia after cardiac arrest: performance characteristics and safety of surface cooling with or without endovascular cooling. Neurocrit Care 7(2):109\u2013118","journal-title":"Neurocrit Care"},{"issue":"1\u20132","key":"2804_CR87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0169-328X(00)00252-7","volume":"86","author":"L Friedman","year":"2001","unstructured":"Friedman L et al (2001) Intraischemic but not postischemic hypothermia prevents non-selective hippocampal downregulation of AMPA and NMDA receptor gene expression after global ischemia. Mol Brain Res 86(1\u20132):34\u201347","journal-title":"Mol Brain Res"},{"issue":"10","key":"2804_CR88","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/acem.13217","volume":"24","author":"M Ganetsky","year":"2017","unstructured":"Ganetsky M et al (2017) Risk of intracranial hemorrhage in ground-level fall with antiplatelet or anticoagulant agents. Acad Emerg Med 24(10):1258\u20131266","journal-title":"Acad Emerg Med"},{"issue":"7","key":"2804_CR89","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.03.005","volume":"22","author":"CM Geeganage","year":"2013","unstructured":"Geeganage CM et al (2013) Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis 22(7):1018\u20131027","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"2804_CR90","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4103\/0028-3886.166538","volume":"63","author":"S Ghosh","year":"2015","unstructured":"Ghosh S et al (2015) The effect of citicoline on stroke: a comparative study from the Eastern part of India. Neurol India 63(5):697","journal-title":"Neurol India"},{"issue":"4","key":"2804_CR91","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000087705","volume":"20","author":"AK Gilligan","year":"2005","unstructured":"Gilligan AK et al (2005) Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit? Cerebrovasc Dis 20(4):239\u2013244","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"2804_CR92","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0895-4356(95)00039-9","volume":"48","author":"M Giroud","year":"1995","unstructured":"Giroud M et al (1995) Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 48(11):1343\u20131348","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2804_CR93","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","volume":"8","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Evans MA (2008) Statin adverse effects. Am J Cardiovasc Drugs 8(6):373\u2013418","journal-title":"Am J Cardiovasc Drugs"},{"key":"2804_CR94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fneur.2011.00004","volume":"2","author":"FP Gonz\u00e1lez-Ibarra","year":"2011","unstructured":"Gonz\u00e1lez-Ibarra FP, Varon J, L\u00f3pez-Meza EG (2011) Therapeutic hypothermia: critical review of the molecular mechanisms of action. Front Neurol 2:4","journal-title":"Front Neurol"},{"issue":"16","key":"2804_CR95","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1523\/JNEUROSCI.17-16-06179.1997","volume":"17","author":"JA Gorter","year":"1997","unstructured":"Gorter JA et al (1997) Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 17(16):6179\u20136188","journal-title":"J Neurosci"},{"key":"2804_CR96","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yebeh.2014.04.009","volume":"36","author":"T Gouveia","year":"2014","unstructured":"Gouveia T et al (2014) Lovastatin decreases the synthesis of inflammatory mediators during epileptogenesis in the hippocampus of rats submitted to pilocarpine-induced epilepsy. Epilepsy Behav 36:68\u201373","journal-title":"Epilepsy Behav"},{"issue":"10029","key":"2804_CR97","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. The Lancet 387(10029):1723\u20131731","journal-title":"The Lancet"},{"key":"2804_CR98","unstructured":"Granfeldt A (2012) Organ dysfunction following regional and global is-chemia\/reperfusion"},{"issue":"2","key":"2804_CR99","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/14728222.12.2.159","volume":"12","author":"I Gravanis","year":"2008","unstructured":"Gravanis I, Tsirka SE (2008) Tissue-type plasminogen activator as a therapeutic target in stroke. Expert Opin Ther Targets 12(2):159\u2013170","journal-title":"Expert Opin Ther Targets"},{"issue":"15\u201316","key":"2804_CR100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.drudis.2006.06.001","volume":"11","author":"AR Green","year":"2006","unstructured":"Green AR, Shuaib A (2006) Therapeutic strategies for the treatment of stroke. Drug Discovery Today 11(15\u201316):681\u2013693","journal-title":"Drug Discovery Today"},{"key":"2804_CR101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1538-7836.2007.02491.x","volume":"5","author":"J Griffin","year":"2007","unstructured":"Griffin J et al (2007) Activated protein C. J Thromb Haemost 5:73\u201380","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2804_CR102","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1474-4422(15)00012-5","volume":"14","author":"Group, I.-C.","year":"2015","unstructured":"Group, I.-C. (2015) Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol 14(5):485\u2013496","journal-title":"Lancet Neurol"},{"issue":"2","key":"2804_CR103","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3174\/ajnr.A2346","volume":"32","author":"IQ Grunwald","year":"2011","unstructured":"Grunwald IQ et al (2011) Endovascular stroke treatment today. Am J Neuroradiol 32(2):238\u2013243","journal-title":"Am J Neuroradiol"},{"issue":"8","key":"2804_CR104","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1197\/j.aem.2006.03.559","volume":"13","author":"KZ Guluma","year":"2006","unstructured":"Guluma KZ et al (2006) A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology. Acad Emerg Med 13(8):820\u2013827","journal-title":"Acad Emerg Med"},{"issue":"2","key":"2804_CR105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nurx.2006.01.007","volume":"3","author":"A Gunn","year":"2006","unstructured":"Gunn A, Thoresen M (2006) Hypothermic neuroprotection. NeuroRx 3(2):154\u2013169","journal-title":"NeuroRx"},{"issue":"2","key":"2804_CR106","first-page":"99","volume":"54","author":"YK Gupta","year":"2010","unstructured":"Gupta YK, Briyal S, Gulati A (2010) Therapeutic potential of herbal drugs in cerebral ischemia. Indian J Physiol Pharmacol 54(2):99\u2013122","journal-title":"Indian J Physiol Pharmacol"},{"issue":"5","key":"2804_CR107","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/nat.2020.0844","volume":"30","author":"NS Hamedani","year":"2020","unstructured":"Hamedani NS et al (2020) Selective modulation of the protease activated protein C using exosite inhibiting aptamers. Nucleic Acid Ther 30(5):276\u2013288","journal-title":"Nucleic Acid Ther"},{"issue":"7","key":"2804_CR108","doi-asserted-by":"crossref","first-page":"e0134543","DOI":"10.1371\/journal.pone.0134543","volume":"10","author":"L Han","year":"2015","unstructured":"Han L et al (2015) Human urinary kallidinogenase promotes angiogenesis and cerebral perfusion in experimental stroke. PLoS ONE 10(7):e0134543","journal-title":"PLoS ONE"},{"issue":"4","key":"2804_CR109","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOL.0b013e32825a6773","volume":"18","author":"CR Harper","year":"2007","unstructured":"Harper CR, Jacobson TA (2007) The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol 18(4):401\u2013408","journal-title":"Curr Opin Lipidol"},{"key":"2804_CR110","doi-asserted-by":"crossref","unstructured":"Hart A, Sibai BM (2013) Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin Perinatol 37(4):207\u2013224","DOI":"10.1053\/j.semperi.2013.04.001"},{"key":"2804_CR111","doi-asserted-by":"crossref","first-page":"117450","DOI":"10.1016\/j.lfs.2020.117450","volume":"256","author":"M Hassanipour","year":"2020","unstructured":"Hassanipour M et al (2020) Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke. Life Sci 256:117450","journal-title":"Life Sci"},{"issue":"9149","key":"2804_CR112","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","volume":"353","author":"C Hawkey","year":"1999","unstructured":"Hawkey C (1999) COX-2 inhibitors. Lancet 353(9149):307\u2013314","journal-title":"Lancet"},{"key":"2804_CR113","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/B978-0-444-63327-9.00010-2","volume":"207","author":"SA Hays","year":"2013","unstructured":"Hays SA, Rennaker RL, Kilgard MP (2013) Targeting plasticity with vagus nerve stimulation to treat neurological disease. Prog Brain Res 207:275\u2013299","journal-title":"Prog Brain Res"},{"issue":"5","key":"2804_CR114","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","volume":"36","author":"HC Helms","year":"2016","unstructured":"Helms HC et al (2016) In vitro models of the blood\u2013brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab 36(5):862\u2013890","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"2804_CR115","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill III","year":"2015","unstructured":"Hemphill JC III et al (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 46(7):2032\u20132060","journal-title":"Stroke"},{"issue":"2","key":"2804_CR116","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/14656560802636888","volume":"10","author":"Y Higashi","year":"2009","unstructured":"Higashi Y (2009) Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress. Expert Opin Pharmacother 10(2):323\u2013331","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"2804_CR117","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/157489006775244191","volume":"1","author":"Y Higashi","year":"2006","unstructured":"Higashi Y et al (2006) Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov (Discontinued) 1(1):85\u201393","journal-title":"Recent Pat Cardiovasc Drug Discov (Discontinued)"},{"issue":"4","key":"2804_CR118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6104","volume":"11","author":"CW Hoedemaekers","year":"2007","unstructured":"Hoedemaekers CW et al (2007) Comparison of cooling methods to induce and maintain normo-and hypothermia in intensive care unit patients: a prospective intervention study. Crit Care 11(4):1\u20139","journal-title":"Crit Care"},{"issue":"7","key":"2804_CR119","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1538-7836.2006.01928.x","volume":"4","author":"M Hovens","year":"2006","unstructured":"Hovens M et al (2006) Aspirin in the prevention and treatment of venous thromboembolism. J Thromb Haemost 4(7):1470\u20131475","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2804_CR120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-1027-y","volume":"15","author":"Q Huang","year":"2018","unstructured":"Huang Q et al (2018) A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke. J Neuroinflammation 15(1):1\u201316","journal-title":"J Neuroinflammation"},{"issue":"4","key":"2804_CR121","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/gt.2016.11","volume":"23","author":"E Hudry","year":"2016","unstructured":"Hudry E et al (2016) Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Ther 23(4):380\u2013392","journal-title":"Gene Ther"},{"key":"2804_CR122","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.reth.2021.09.009","volume":"18","author":"MD Hurd","year":"2021","unstructured":"Hurd MD et al (2021) Current status of ischemic stroke treatment: From thrombolysis to potential regenerative medicine. Regenerative Therapy 18:408\u2013417","journal-title":"Regenerative Therapy"},{"key":"2804_CR123","doi-asserted-by":"crossref","first-page":"172762","DOI":"10.1016\/j.ejphar.2019.172762","volume":"866","author":"J Hybiak","year":"2020","unstructured":"Hybiak J et al (2020) Aspirin and its pleiotropic application. Eur J Pharmacol 866:172762","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2804_CR124","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2020.12.060","volume":"77","author":"G Ikeda","year":"2021","unstructured":"Ikeda G et al (2021) Mitochondria-rich extracellular vesicles from autologous stem cell\u2013derived cardiomyocytes restore energetics of ischemic myocardium. J Am Coll Cardiol 77(8):1073\u20131088","journal-title":"J Am Coll Cardiol"},{"key":"2804_CR125","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2147\/IJN.S127683","volume":"12","author":"H Jahangirian","year":"2017","unstructured":"Jahangirian H et al (2017) A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Int J Nanomed 12:2957","journal-title":"Int J Nanomed"},{"issue":"3","key":"2804_CR126","doi-asserted-by":"crossref","first-page":"4A","DOI":"10.1016\/j.amjcard.2008.11.017","volume":"103","author":"LK Jennings","year":"2009","unstructured":"Jennings LK (2009) Role of platelets in atherothrombosis. Am J Cardiol 103(3):4A-10A","journal-title":"Am J Cardiol"},{"key":"2804_CR127","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","volume":"163","author":"X Jiang","year":"2018","unstructured":"Jiang X et al (2018) Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 163:144\u2013171","journal-title":"Prog Neurobiol"},{"issue":"2","key":"2804_CR128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1874467209666160112125446","volume":"10","author":"X Jiao","year":"2017","unstructured":"Jiao X et al (2017) Mevalonate cascade and neurodevelopmental and neurodegenerative diseases: Future targets for therapeutic application. Curr Mol Pharmacol 10(2):115\u2013140","journal-title":"Curr Mol Pharmacol"},{"issue":"4","key":"2804_CR129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1474-4422(09)70023-7","volume":"8","author":"SC Johnston","year":"2009","unstructured":"Johnston SC, Mendis S, Mathers CD (2009) Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 8(4):345\u2013354","journal-title":"Lancet Neurol"},{"issue":"8833","key":"2804_CR130","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0140-6736(92)92619-Q","volume":"340","author":"S Juul-Moller","year":"1992","unstructured":"Juul-Moller S et al (1992) Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Lancet 340(8833):1421\u20131425","journal-title":"The Lancet"},{"issue":"2","key":"2804_CR131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/ijmr.IJMR_516_15","volume":"146","author":"S Kamalakannan","year":"2017","unstructured":"Kamalakannan S et al (2017) Incidence & prevalence of stroke in India: a systematic review. Indian J Med Res 146(2):175","journal-title":"Indian J Med Res"},{"key":"2804_CR132","doi-asserted-by":"crossref","unstructured":"Kamath M et al (2010) Longer-term effects of implanted vagal nerve stimulation. J Long-Term Eff Med Implants 20(3):251\u2013267","DOI":"10.1615\/JLongTermEffMedImplants.v20.i3.60"},{"key":"2804_CR133","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-981-10-0965-5_9","volume-title":"Acute Ischemic Stroke","author":"D-H Kang","year":"2017","unstructured":"Kang D-H (2017) History and overview of endovascular stroke therapy. Acute Ischemic Stroke. Springer, pp 139\u2013153"},{"issue":"10","key":"2804_CR134","first-page":"65","volume":"4","author":"N Kanyal","year":"2015","unstructured":"Kanyal N (2015) The science of ischemic stroke: pathophysiology & pharmacological treatment. Int J Pharm Res Rev 4(10):65\u201384","journal-title":"Int J Pharm Res Rev"},{"issue":"6","key":"2804_CR135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00270-011-0258-z","volume":"34","author":"D Karnabatidis","year":"2011","unstructured":"Karnabatidis D et al (2011) Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovasc Intervent Radiol 34(6):1123\u20131136","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"24","key":"2804_CR136","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM199512143332402","volume":"333","author":"R Kay","year":"1995","unstructured":"Kay R et al (1995) Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333(24):1588\u20131594","journal-title":"N Engl J Med"},{"issue":"5","key":"2804_CR137","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neurad.2019.03.014","volume":"46","author":"R Kharouba","year":"2019","unstructured":"Kharouba R et al (2019) Number of stentriever passes and outcome after thrombectomy in stroke. J Neuroradiol 46(5):327\u2013330","journal-title":"J Neuroradiol"},{"issue":"4","key":"2804_CR138","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11239-018-1721-3","volume":"46","author":"B Kheiri","year":"2018","unstructured":"Kheiri B et al (2018) Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials. J Thromb Thrombolysis 46(4):440\u2013450","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"2804_CR139","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.3390\/ijms140713909","volume":"14","author":"K Kikuchi","year":"2013","unstructured":"Kikuchi K et al (2013) The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease. Int J Mol Sci 14(7):13909\u201313930","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2804_CR140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/2394-8108.164997","volume":"1","author":"JY Kim","year":"2015","unstructured":"Kim JY, Yenari MA (2015) Hypothermia for treatment of stroke. Brain Circulation 1(1):14","journal-title":"Brain Circulation"},{"key":"2804_CR141","unstructured":"Kleinpell RM, Munro CL, Giuliano KK (2008) Targeting health care\u2013associated infections: evidence-based strategies. In: Patient safety and quality: an evidence-based handbook for nurses"},{"issue":"12","key":"2804_CR142","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/ijms18122756","volume":"18","author":"T Knecht","year":"2017","unstructured":"Knecht T et al (2017) Adjunctive therapy approaches for ischemic stroke: innovations to expand time window of treatment. Int J Mol Sci 18(12):2756","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2804_CR143","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/bc.bc_21_18","volume":"4","author":"T Knecht","year":"2018","unstructured":"Knecht T, Borlongan C, dela Pe\u00f1a I. (2018) Combination therapy for ischemic stroke: novel approaches to lengthen therapeutic window of tissue plasminogen activator. Brain Circ 4(3):99","journal-title":"Brain Circ"},{"issue":"8","key":"2804_CR144","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11748-018-0956-4","volume":"66","author":"M Koga","year":"2018","unstructured":"Koga M et al (2018) Acute ischemic stroke as a complication of Stanford type A acute aortic dissection: a review and proposed clinical recommendations for urgent diagnosis. Gen Thorac Cardiovasc Surg 66(8):439\u2013445","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"1","key":"2804_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5469\/neuroint.2012.7.1.1","volume":"7","author":"JS Koh","year":"2012","unstructured":"Koh JS et al (2012) Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: a systematic review. Neurointervention 7(1):1\u20139","journal-title":"Neurointervention"},{"issue":"8","key":"2804_CR146","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/01.STR.32.8.1847","volume":"32","author":"DW Krieger","year":"2001","unstructured":"Krieger DW et al (2001) Cooling for acute ischemic brain damage (COOL AID) An open pilot study of induced hypothermia in acute ischemic stroke. Stroke 32(8):1847\u20131854","journal-title":"Stroke"},{"issue":"5","key":"2804_CR147","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.STR.27.5.852","volume":"27","author":"J Krupinski","year":"1996","unstructured":"Krupinski J et al (1996) Increased expression of TGF-\u03b21 in brain tissue after ischemic stroke in humans. Stroke 27(5):852\u2013857","journal-title":"Stroke"},{"key":"2804_CR148","doi-asserted-by":"crossref","unstructured":"Kumar SS, Sabu A (2019) Fibrinolytic enzymes for thrombolytic therapy. Review Adv Exp Med Biol 1148:345\u2013381","DOI":"10.1007\/978-981-13-7709-9_15"},{"key":"2804_CR149","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuropharm.2017.08.025","volume":"134","author":"K Kurisu","year":"2018","unstructured":"Kurisu K, Yenari MA (2018) Therapeutic hypothermia for ischemic stroke; pathophysiology and future promise. Neuropharmacology 134:302\u2013309","journal-title":"Neuropharmacology"},{"issue":"2","key":"2804_CR150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/092986707779313381","volume":"14","author":"V Lahera","year":"2007","unstructured":"Lahera V et al (2007) Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem 14(2):243\u2013248","journal-title":"Curr Med Chem"},{"issue":"1","key":"2804_CR151","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1139\/Y05-143","volume":"84","author":"AY Lai","year":"2006","unstructured":"Lai AY, Todd KG (2006) Microglia in cerebral ischemia: molecular actions and interactions. Can J Physiol Pharmacol 84(1):49\u201359","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"2804_CR152","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","volume":"23","author":"A Lanas","year":"2007","unstructured":"Lanas A, Scheiman J (2007) Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 23(1):163\u2013173","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"2804_CR153","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1517\/14656566.2010.493558","volume":"11","author":"PA Lapchak","year":"2010","unstructured":"Lapchak PA (2010) A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother 11(10):1753\u20131763","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"2804_CR154","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/14728214.12.1.97","volume":"12","author":"PA Lapchak","year":"2007","unstructured":"Lapchak PA, Araujo DM (2007) Advances in ischemic stroke treatment: neuroprotective and combination therapies. Expert Opin Emerg Drugs 12(1):97\u2013112","journal-title":"Expert Opin Emerg Drugs"},{"key":"2804_CR155","doi-asserted-by":"crossref","unstructured":"Lapchak PA (2011) Emerging therapies: pleiotropic multi-target drugs to treat stroke victims. Trans Stroke Res 2(2):129\u2013135","DOI":"10.1007\/s12975-011-0074-4"},{"issue":"11","key":"2804_CR156","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/pharmaceutics12111022","volume":"12","author":"P Lara","year":"2020","unstructured":"Lara P et al (2020) Exploiting the natural properties of extracellular vesicles in targeted delivery towards specific cells and tissues. Pharmaceutics 12(11):1022","journal-title":"Pharmaceutics"},{"issue":"6738","key":"2804_CR157","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1038\/399a007","volume":"399","author":"J-M Lee","year":"1999","unstructured":"Lee J-M, Zipfel GJ, Choi DW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399(6738):A7\u2013A14","journal-title":"Nature"},{"issue":"8","key":"2804_CR158","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/biomedicines9080985","volume":"9","author":"C-K Lee","year":"2021","unstructured":"Lee C-K et al (2021) Lipids and lipoproteins in health and disease: focus on targeting atherosclerosis. Biomedicines 9(8):985","journal-title":"Biomedicines"},{"issue":"1","key":"2804_CR159","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-0173(02)00157-1","volume":"39","author":"RR Leker","year":"2002","unstructured":"Leker RR, Shohami E (2002) Cerebral ischemia and trauma\u2014different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev 39(1):55\u201373","journal-title":"Brain Res Rev"},{"issue":"8","key":"2804_CR160","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0002-9149(97)00604-8","volume":"80","author":"H Lethen","year":"1997","unstructured":"Lethen H et al (1997) Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 80(8):1066\u20131069","journal-title":"Am J Cardiol"},{"issue":"16","key":"2804_CR161","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/cphc.201701294","volume":"19","author":"Y Li","year":"2018","unstructured":"Li Y et al (2018) Adaptive materials based on iron oxide nanoparticles for bone regeneration. ChemPhysChem 19(16):1965\u20131979","journal-title":"ChemPhysChem"},{"key":"2804_CR162","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainresbull.2018.11.006","volume":"144","author":"Y Li","year":"2019","unstructured":"Li Y et al (2019) New progress in the approaches for blood\u2013brain barrier protection in acute ischemic stroke. Brain Res Bull 144:46\u201357","journal-title":"Brain Res Bull"},{"key":"2804_CR163","doi-asserted-by":"crossref","unstructured":"Li Y et al (2021) Extracellular vesicle application as a novel therapeutic strategy for ischemic stroke. Transl Stroke Res 1\u201317","DOI":"10.1007\/s12975-021-00915-3"},{"issue":"6","key":"2804_CR164","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/01.mol.0000191913.16321.60","volume":"16","author":"JK Liao","year":"2005","unstructured":"Liao JK (2005a) Clinical implications for statin pleiotropy. Curr Opin Lipidol 16(6):624\u2013629","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"2804_CR165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjcard.2005.06.009","volume":"96","author":"JK Liao","year":"2005","unstructured":"Liao JK (2005b) Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96(5):24\u201333","journal-title":"Am J Cardiol"},{"issue":"10","key":"2804_CR166","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrcardio.2011.112","volume":"8","author":"GY Lip","year":"2011","unstructured":"Lip GY (2011) The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol 8(10):602\u2013606","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2804_CR167","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2741\/2104","volume":"12","author":"L Liu","year":"2007","unstructured":"Liu L, Yenari MA (2007) Therapeutic hypothermia: neuroprotective mechanisms. Front Biosci-Landmark 12(3):816\u2013825","journal-title":"Front Biosci-Landmark"},{"issue":"5","key":"2804_CR168","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrn1106","volume":"4","author":"EH Lo","year":"2003","unstructured":"Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4(5):399\u2013414","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"2804_CR169","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","volume":"16","author":"N Logallo","year":"2017","unstructured":"Logallo N et al (2017) Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol 16(10):781\u2013788","journal-title":"Lancet Neurol"},{"issue":"9","key":"2804_CR170","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd4623","volume":"14","author":"JO Lundberg","year":"2015","unstructured":"Lundberg JO, Gladwin MT, Weitzberg E (2015) Strategies to increase nitric oxide signalling in cardiovascular disease. Nat Rev Drug Discovery 14(9):623\u2013641","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"2804_CR171","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.01.001","volume":"14","author":"PD Lyden","year":"2005","unstructured":"Lyden PD et al (2005) Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis 14(3):107\u2013114","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2804_CR172","doi-asserted-by":"crossref","first-page":"104539","DOI":"10.1016\/j.neuint.2019.104539","volume":"131","author":"J Ma","year":"2019","unstructured":"Ma J et al (2019) Vagus nerve stimulation as a promising adjunctive treatment for ischemic stroke. Neurochem Int 131:104539","journal-title":"Neurochem Int"},{"issue":"4","key":"2804_CR173","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjp.0704549","volume":"135","author":"DJ MacEwan","year":"2002","unstructured":"MacEwan DJ (2002) TNF ligands and receptors\u2013a matter of life and death. Br J Pharmacol 135(4):855","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2804_CR174","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1474-4422(11)70066-7","volume":"10","author":"R Macrez","year":"2011","unstructured":"Macrez R et al (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 10(5):471\u2013480","journal-title":"Lancet Neurol"},{"issue":"1","key":"2804_CR175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00062-018-0742-9","volume":"30","author":"C Maegerlein","year":"2020","unstructured":"Maegerlein C et al (2020) Further development of combined techniques using stent retrievers, aspiration catheters and BGC. Clin Neuroradiol 30(1):59\u201365","journal-title":"Clin Neuroradiol"},{"key":"2804_CR176","doi-asserted-by":"crossref","unstructured":"Marques BL, Carvalho GA, Freitas EM, Chiareli RA, Barbosa TG, Di Ara\u00fajo AG,\u00a0Nogueira YL, Ribeiro RI, Parreira RC, Vieira MS, Resende RR, Gomez RS, Oliveira-Lima OC,\u00a0Pinto MC (2019) The role of neurogenesis in neurorepair after ischemic stroke.\u00a0Semin Cell Dev Biol 95:98\u2013110","DOI":"10.1016\/j.semcdb.2018.12.003"},{"key":"2804_CR177","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/JEP.S63544","volume":"7","author":"MY Martynov","year":"2015","unstructured":"Martynov MY, Gusev EI (2015) Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke. J Exp Pharmacol 7:17","journal-title":"J Exp Pharmacol"},{"issue":"588","key":"2804_CR178","doi-asserted-by":"crossref","first-page":"eabb1498","DOI":"10.1126\/scitranslmed.abb1498","volume":"13","author":"D Mayor-Nunez","year":"2021","unstructured":"Mayor-Nunez D et al (2021) Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke. Sci Transl Med 13(588):eabb1498","journal-title":"Sci Transl Med"},{"key":"2804_CR179","doi-asserted-by":"crossref","unstructured":"McArthur KS, Quinn TJ, Higgins P, Langhorne P (2011) Post-acute care and secondary prevention after ischaemic stroke. BMJ 342:d2083","DOI":"10.1136\/bmj.d2083"},{"key":"2804_CR180","doi-asserted-by":"crossref","unstructured":"McCarthy R, Mirza M, Johnson S, Dwivedi A, Gunning G, Vale D, Gilvarry M (2022) Aspects of ischemic stroke biomechanics derived using ex-vivo and in-vitro methods relating to mechanical thrombectomy. J Biomech 131:110900","DOI":"10.1016\/j.jbiomech.2021.110900"},{"issue":"1","key":"2804_CR181","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresrev.2006.11.003","volume":"54","author":"SL Mehta","year":"2007","unstructured":"Mehta SL, Manhas N, Raghubir R (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54(1):34\u201366","journal-title":"Brain Res Rev"},{"key":"2804_CR182","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/VHRM.S3848","volume":"5","author":"G Melandri","year":"2009","unstructured":"Melandri G et al (2009) Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Vascular Health Risk Manag 5:249","journal-title":"Vascular Health Risk Manag"},{"issue":"1","key":"2804_CR183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13695-0","volume":"10","author":"EC Meyers","year":"2019","unstructured":"Meyers EC et al (2019) Enhancing plasticity in central networks improves motor and sensory recovery after nerve damage. Nat Commun 10(1):1\u201314","journal-title":"Nat Commun"},{"key":"2804_CR184","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.csbj.2019.06.023","volume":"17","author":"J Mican","year":"2019","unstructured":"Mican J et al (2019) Structural biology and protein engineering of thrombolytics. Comput Struct Biotechnol J 17:917\u2013938","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"2804_CR185","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrd2957","volume":"9","author":"AD Michelson","year":"2010","unstructured":"Michelson AD (2010) Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discovery 9(2):154\u2013169","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"2804_CR186","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s003950050105","volume":"93","author":"T Miki","year":"1998","unstructured":"Miki T et al (1998) Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol 93(5):372\u2013383","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"2804_CR187","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/joim.12387","volume":"278","author":"R Mikulik","year":"2015","unstructured":"Mikulik R, Wahlgren N (2015) Treatment of acute stroke: an update. J Intern Med 278(2):145\u2013165","journal-title":"J Intern Med"},{"issue":"10","key":"2804_CR188","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/STR.0b013e3181e7512b","volume":"41","author":"EL Miller","year":"2010","unstructured":"Miller EL et al (2010) Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke 41(10):2402\u20132448","journal-title":"Stroke"},{"key":"2804_CR189","doi-asserted-by":"crossref","unstructured":"Minematsu K et al (2013) Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis 22(5):571\u2013600","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.001"},{"issue":"2","key":"2804_CR190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/14737175.5.2.211","volume":"5","author":"J Montaner","year":"2005","unstructured":"Montaner J (2005) Treatment with statins in the acute phase of ischemic stroke. Expert Rev Neurother 5(2):211\u2013221","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"2804_CR191","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.beha.2004.03.003","volume":"17","author":"RL Mueller","year":"2004","unstructured":"Mueller RL (2004) First-generation agents: aspirin, heparin and coumarins. Best Pract Res Clin Haematol 17(1):23\u201353","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"2804_CR192","first-page":"481","volume":"72","author":"C Murray","year":"1994","unstructured":"Murray C, Lopez AD (1994) Quantifying disability: data, methods and results. Bull World Health Organ 72(3):481","journal-title":"Bull World Health Organ"},{"issue":"10009","key":"2804_CR193","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","volume":"386","author":"CJ Murray","year":"2015","unstructured":"Murray CJ et al (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition. Lancet 386(10009):2145\u20132191","journal-title":"Lancet"},{"issue":"1","key":"2804_CR194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.42.1.1","volume":"42","author":"J Mustard","year":"1970","unstructured":"Mustard J, Packham M (1970) Thromboembolism: a manifestation of the response of blood to injury. Circulation 42(1):1\u201321","journal-title":"Circulation"},{"issue":"5","key":"2804_CR195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/bjaceaccp\/mkh045","volume":"4","author":"VP Nair","year":"2004","unstructured":"Nair VP, Hunter JM (2004) Anticholinesterases and anticholinergic drugs. Continuing Education in Anaesthesia, Critical Care & Pain 4(5):164\u2013168","journal-title":"Continuing Education in Anaesthesia, Critical Care & Pain"},{"issue":"9","key":"2804_CR196","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/STROKEAHA.110.589606","volume":"41","author":"J Nakagawara","year":"2010","unstructured":"Nakagawara J et al (2010) Thrombolysis with 06 mg\/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-marketing alteplase registration study (J-MARS). Stroke 41(9):1984\u20131989","journal-title":"Stroke"},{"issue":"1","key":"2804_CR197","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12035-007-8013-9","volume":"37","author":"VP Nakka","year":"2008","unstructured":"Nakka VP et al (2008) Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol 37(1):7\u201338","journal-title":"Mol Neurobiol"},{"issue":"9849","key":"2804_CR198","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(12)61299-9","volume":"380","author":"RG Nogueira","year":"2012","unstructured":"Nogueira RG et al (2012) Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 380(9849):1231\u20131240","journal-title":"Lancet"},{"key":"2804_CR199","doi-asserted-by":"crossref","unstructured":"O\u2019Carroll CB, Brown BL, Freeman WD (2021) Intracerebral hemorrhage: a common yet disproportionately deadly stroke subtype. Mayo Clin Proc 96(6):1639\u20131654","DOI":"10.1016\/j.mayocp.2020.10.034"},{"issue":"1","key":"2804_CR200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/physrev.00039.2006","volume":"88","author":"TP Obrenovitch","year":"2008","unstructured":"Obrenovitch TP (2008) Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 88(1):211\u2013247","journal-title":"Physiol Rev"},{"issue":"6","key":"2804_CR201","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1592\/phco.21.7.767.34577","volume":"21","author":"A Orsi","year":"2001","unstructured":"Orsi A, Sherman O, Woldeselassie Z (2001) Simvastatin-associated memory loss. Pharmacotherapy: J Human Pharmacol Drug Therapy 21(6):767\u2013769","journal-title":"Pharmacotherapy: J Human Pharmacol Drug Therapy"},{"issue":"3","key":"2804_CR202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s13311-011-0053-1","volume":"8","author":"B Ovbiagele","year":"2011","unstructured":"Ovbiagele B, Nguyen-Huynh MN (2011) Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics 8(3):319\u2013329","journal-title":"Neurotherapeutics"},{"issue":"1","key":"2804_CR203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11910-003-0031-z","volume":"3","author":"B Ovbiagele","year":"2003","unstructured":"Ovbiagele B et al (2003a) Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 3(1):9\u201320","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"2804_CR204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11936-003-0033-9","volume":"5","author":"B Ovbiagele","year":"2003","unstructured":"Ovbiagele B et al (2003b) Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. Curr Treat Options Cardiovasc Med 5(6):441\u2013449","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2804_CR205","doi-asserted-by":"crossref","unstructured":"\u00d6zben T (1998) Pathophysiology of cerebral ischemia: mechanisms involved in neuronal damage. In: Free radicals, oxidative stress, and antioxidants: Pathological and physiological significance. Springer US, Boston, pp 163\u2013187","DOI":"10.1007\/978-1-4757-2907-8_17"},{"issue":"8","key":"2804_CR206","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/STROKEAHA.109.554824","volume":"40","author":"K-P Park","year":"2009","unstructured":"Park K-P et al (2009) Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke 40(8):2836\u20132842","journal-title":"Stroke"},{"issue":"12","key":"2804_CR207","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa1109842","volume":"366","author":"M Parsons","year":"2012","unstructured":"Parsons M et al (2012) A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 366(12):1099\u20131107","journal-title":"N Engl J Med"},{"key":"2804_CR208","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/B978-0-12-813456-6.00050-3","volume-title":"Platelets","author":"C Patrono","year":"2019","unstructured":"Patrono C (2019) Aspirin. Platelets. Elsevier, pp 921\u2013936"},{"key":"2804_CR209","doi-asserted-by":"crossref","unstructured":"Patrono C, Rocca B (2012) Aspirin and other COX-1 inhibitors. In: Gresele P, Born G, Patrono C, Page C (eds) Antiplatelet agents. Handbook of experimental pharmacology, vol 210. Springer, Berlin, Heidelberg, pp 137\u2013164","DOI":"10.1007\/978-3-642-29423-5_6"},{"key":"2804_CR210","doi-asserted-by":"crossref","first-page":"113518","DOI":"10.1016\/j.expneurol.2020.113518","volume":"335","author":"S Paul","year":"2021","unstructured":"Paul S, Candelario-Jalil E (2021) Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol 335:113518","journal-title":"Exp Neurol"},{"key":"2804_CR211","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainres.2008.06.123","volume":"1233","author":"N Pavlichenko","year":"2008","unstructured":"Pavlichenko N et al (2008) Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res 1233:203\u2013213","journal-title":"Brain Res"},{"issue":"2","key":"2804_CR212","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00005082-200201000-00007","volume":"16","author":"S Penckofer","year":"2002","unstructured":"Penckofer S, Schwertz D, Florczak K (2002) Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs 16(2):68\u201385","journal-title":"J Cardiovasc Nurs"},{"issue":"8","key":"2804_CR213","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/neurintsurg-2016-012533","volume":"9","author":"S Peschillo","year":"2017","unstructured":"Peschillo S et al (2017) A comparison of acute vascular damage caused by ADAPT versus a stent retriever device after thrombectomy in acute ischemic stroke: a histological and ultrastructural study in an animal model. J Neurointerv Surg 9(8):743\u2013749","journal-title":"J Neurointerv Surg"},{"key":"2804_CR214","doi-asserted-by":"crossref","unstructured":"Phipps MS, Cronin CA (2020) Management of acute ischemic stroke. BMJ 368:l6983","DOI":"10.1136\/bmj.l6983"},{"issue":"3","key":"2804_CR215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc5956","volume":"11","author":"N Pichon","year":"2007","unstructured":"Pichon N et al (2007) Efficacy of and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system. Crit Care 11(3):1\u20138","journal-title":"Crit Care"},{"issue":"1","key":"2804_CR216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34082-7","volume":"8","author":"A Piebalgs","year":"2018","unstructured":"Piebalgs A et al (2018) Computational simulations of thrombolytic therapy in acute ischaemic stroke. Sci Rep 8(1):1\u201313","journal-title":"Sci Rep"},{"issue":"7","key":"2804_CR217","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1097\/CCM.0b013e3181aa5241","volume":"37","author":"KH Polderman","year":"2009","unstructured":"Polderman KH (2009) Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 37(7):S186\u2013S202","journal-title":"Crit Care Med"},{"issue":"3","key":"2804_CR218","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/CCM.0b013e3181962ad5","volume":"37","author":"KH Polderman","year":"2009","unstructured":"Polderman KH, Herold I (2009) Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med 37(3):1101\u20131120","journal-title":"Crit Care Med"},{"issue":"8","key":"2804_CR219","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1051-0443(07)61575-9","volume":"12","author":"D Ponec","year":"2001","unstructured":"Ponec D et al (2001) Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial\u2014the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 12(8):951\u2013955","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"2804_CR220","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/adc.65.8.826","volume":"65","author":"J Porter","year":"1990","unstructured":"Porter J et al (1990) Trends in the incidence of Reye\u2019s syndrome and the use of aspirin. Arch Dis Child 65(8):826\u2013829","journal-title":"Arch Dis Child"},{"issue":"9","key":"2804_CR221","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/1545968318798955","volume":"32","author":"L Qing","year":"2018","unstructured":"Qing L et al (2018) Exosomes and their MicroRNA cargo: new players in peripheral nerve regeneration. Neurorehabil Neural Repair 32(9):765\u2013776","journal-title":"Neurorehabil Neural Repair"},{"issue":"6","key":"2804_CR222","first-page":"11","volume":"2","author":"I Qureshi","year":"2010","unstructured":"Qureshi I, Endres J (2010) Citicoline: a novel therapeutic agent with neuroprotective, neuromodulatory, and neuroregenerative properties. Natural Med J 2(6):11\u201325","journal-title":"Natural Med J"},{"issue":"1","key":"2804_CR223","first-page":"62","volume":"23","author":"AA Rabinstein","year":"2017","unstructured":"Rabinstein AA (2017) Treatment of acute ischemic stroke. CONTIN: Lifelong Learn Neurol 23(1):62\u201381","journal-title":"CONTIN: Lifelong Learn Neurol"},{"issue":"2","key":"2804_CR224","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1570161115666161104095522","volume":"15","author":"D Radak","year":"2017","unstructured":"Radak D et al (2017) Apoptosis and acute brain ischemia in ischemic stroke. Curr Vasc Pharmacol 15(2):115\u2013122","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"2804_CR225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ana.410130103","volume":"13","author":"ME Raichle","year":"1983","unstructured":"Raichle ME (1983) The pathophysiology of brain ischemia. Ann Neurol: Official Journal of the American Neurological Association and the Child Neurology Society 13(1):2\u201310","journal-title":"Ann Neurol: Official Journal of the American Neurological Association and the Child Neurology Society"},{"key":"2804_CR226","doi-asserted-by":"crossref","unstructured":"Rajanikant GK et al (2020) Ischemic stroke: an imperative need for effective therapy. In: IschemiRs: MicroRNAs in Ischemic Stroke, Springer, p. 15\u201329","DOI":"10.1007\/978-981-15-4798-0_2"},{"issue":"2","key":"2804_CR227","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0005-2760(77)90188-6","volume":"488","author":"A Raz","year":"1977","unstructured":"Raz A, Minkes MS, Needleman P (1977) Endoperoxides and thromboxanes structural determinants for platelet aggregation and vasoconstriction. Biochim Biophys Acta (BBA)-Lipids Lipid Metab 488(2):305\u2013311","journal-title":"Biochim Biophys Acta (BBA)-Lipids Lipid Metab"},{"issue":"10","key":"2804_CR228","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1474-4422(08)70193-5","volume":"7","author":"MJ Reeves","year":"2008","unstructured":"Reeves MJ et al (2008) Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 7(10):915\u2013926","journal-title":"Lancet Neurol"},{"issue":"3","key":"2804_CR229","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.STR.0000058493.94875.9F","volume":"34","author":"TG Robinson","year":"2003","unstructured":"Robinson TG et al (2003) Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke 34(3):705\u2013712","journal-title":"Stroke"},{"key":"2804_CR230","doi-asserted-by":"crossref","unstructured":"Rodrigo R et al (2013) Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 12(5): 698\u2013714","DOI":"10.2174\/1871527311312050015"},{"issue":"6","key":"2804_CR231","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00637504","volume":"23","author":"L Ross-Lee","year":"1982","unstructured":"Ross-Lee L et al (1982) Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function. Eur J Clin Pharmacol 23(6):545\u2013551","journal-title":"Eur J Clin Pharmacol"},{"issue":"9268","key":"2804_CR232","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(00)04730-9","volume":"357","author":"P Rothwell","year":"2001","unstructured":"Rothwell P (2001) The high cost of not funding stroke research: a comparison with heart disease and cancer. The Lancet 357(9268):1612\u20131616","journal-title":"The Lancet"},{"issue":"3","key":"2804_CR233","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jps.2600610312","volume":"61","author":"M Rowland","year":"1972","unstructured":"Rowland M et al (1972) Absorption kinetics of aspirin in man follow oral administration of an aqueous solution. J Pharm Sci 61(3):379\u2013385","journal-title":"J Pharm Sci"},{"issue":"11","key":"2804_CR234","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","volume":"8","author":"ZM Ruggeri","year":"2002","unstructured":"Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8(11):1227\u20131234","journal-title":"Nat Med"},{"issue":"6","key":"2804_CR235","first-page":"612","volume":"13","author":"D Sacks","year":"2018","unstructured":"Sacks D et al (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13(6):612\u2013632","journal-title":"Int J Stroke"},{"issue":"4","key":"2804_CR236","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11011-017-0021-5","volume":"32","author":"SS Saeedi Saravi","year":"2017","unstructured":"Saeedi Saravi SS et al (2017) The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. Metab Brain Dis 32(4):949\u2013965","journal-title":"Metab Brain Dis"},{"issue":"3","key":"2804_CR237","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s13311-011-0040-6","volume":"8","author":"P Sahota","year":"2011","unstructured":"Sahota P, Savitz SI (2011) Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics 8(3):434\u2013451","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2804_CR238","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14712598.2019.1576630","volume":"19","author":"S Sayad-Fathi","year":"2019","unstructured":"Sayad-Fathi S, Nasiri E, Zaminy A (2019) Advances in stem cell treatment for sciatic nerve injury. Expert Opin Biol Ther 19(4):301\u2013311","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"2804_CR239","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1097\/CCM.0b013e3181aa5bad","volume":"37","author":"DB Seder","year":"2009","unstructured":"Seder DB, Van der Kloot TE (2009) Methods of cooling: practical aspects of therapeutic temperature management. Crit Care Med 37(7):S211\u2013S222","journal-title":"Crit Care Med"},{"key":"2804_CR240","doi-asserted-by":"crossref","first-page":"112512","DOI":"10.1016\/j.bbr.2020.112512","volume":"383","author":"M Shekarian","year":"2020","unstructured":"Shekarian M et al (2020) The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (a\u03b2) peptide. Behav Brain Res 383:112512","journal-title":"Behav Brain Res"},{"key":"2804_CR241","doi-asserted-by":"crossref","first-page":"113125","DOI":"10.1016\/j.biopha.2022.113125","volume":"151","author":"Z Shen","year":"2022","unstructured":"Shen Z et al (2022) Glutamate excitotoxicity: potential therapeutic target for ischemic stroke. Biomed Pharmacother 151:113125","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2804_CR242","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1177\/0271678X18798162","volume":"38","author":"L Shi","year":"2018","unstructured":"Shi L et al (2018) A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion. J Cereb Blood Flow Metab 38(12):2073\u20132091","journal-title":"J Cereb Blood Flow Metab"},{"key":"2804_CR243","doi-asserted-by":"crossref","unstructured":"Shibuya M, Asano T, Sasaki Y (2001) Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Springer, Vienna, pp 201\u2013204","DOI":"10.1007\/978-3-7091-6232-3_42"},{"issue":"2","key":"2804_CR244","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2004.09.055","volume":"1029","author":"H Shichinohe","year":"2004","unstructured":"Shichinohe H et al (2004) Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res 1029(2):200\u2013206","journal-title":"Brain Res"},{"issue":"3","key":"2804_CR245","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11906-011-0195-x","volume":"13","author":"C Sierra","year":"2011","unstructured":"Sierra C, Coca A, Schiffrin EL (2011) Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep 13(3):200\u2013207","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"2804_CR246","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/clpt.1993.115","volume":"54","author":"CA Silagy","year":"1993","unstructured":"Silagy CA et al (1993) Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 54(1):84\u201389","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2804_CR247","first-page":"310","volume":"26","author":"GS Silva","year":"2020","unstructured":"Silva GS, Nogueira RG (2020) Endovascular treatment of acute ischemic stroke. CONTIN: Lifelong Learn Neurol 26(2):310\u2013331","journal-title":"CONTIN: Lifelong Learn Neurol"},{"issue":"8886\u20138887","key":"2804_CR248","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(05)80089-3","volume":"342","author":"ML Simoons","year":"1993","unstructured":"Simoons ML et al (1993) Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. The Lancet 342(8886\u20138887):1523\u20131528","journal-title":"The Lancet"},{"issue":"9","key":"2804_CR249","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1109\/TBME.2007.892921","volume":"54","author":"W Small","year":"2007","unstructured":"Small W et al (2007) Prototype fabrication and preliminary in vitro testing of a shape memory endovascular thrombectomy device. IEEE Trans Biomed Eng 54(9):1657\u20131666","journal-title":"IEEE Trans Biomed Eng"},{"issue":"4","key":"2804_CR250","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.107.497115","volume":"39","author":"WS Smith","year":"2008","unstructured":"Smith WS et al (2008) Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39(4):1205\u20131212","journal-title":"Stroke"},{"issue":"2","key":"2804_CR251","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10522-014-9510-7","volume":"16","author":"J Smith","year":"2015","unstructured":"Smith J et al (2015) Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology 16(2):147\u2013185","journal-title":"Biogerontology"},{"key":"2804_CR252","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fmolb.2018.00120","volume":"5","author":"VF Smolders","year":"2019","unstructured":"Smolders VF et al (2019) Metabolic alterations in cardiopulmonary vascular dysfunction. Front Mol Biosci 5:120","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2804_CR253","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/neurintsurg-2014-011472","volume":"8","author":"S Son","year":"2016","unstructured":"Son S et al (2016) Comparison of Solitaire thrombectomy and Penumbra suction thrombectomy in patients with acute ischemic stroke caused by basilar artery occlusion. J Neurointerv Surg 8(1):13\u201318","journal-title":"J Neurointerv Surg"},{"issue":"6","key":"2804_CR254","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11940-012-0201-x","volume":"14","author":"SS Song","year":"2012","unstructured":"Song SS, Lyden PD (2012) Overview of therapeutic hypothermia. Curr Treat Options Neurol 14(6):541\u2013548","journal-title":"Curr Treat Options Neurol"},{"issue":"7","key":"2804_CR255","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1097\/CCM.0b013e3181aa5fb8","volume":"37","author":"RT Stravitz","year":"2009","unstructured":"Stravitz RT, Larsen FS (2009) Therapeutic hypothermia for acute liver failure. Crit Care Med 37(7):S258\u2013S264","journal-title":"Crit Care Med"},{"issue":"2","key":"2804_CR256","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(07)70031-5","volume":"6","author":"K Strong","year":"2007","unstructured":"Strong K, Mathers C, Bonita R (2007) Preventing stroke: saving lives around the world. The Lancet Neurology 6(2):182\u2013187","journal-title":"The Lancet Neurology"},{"key":"2804_CR257","doi-asserted-by":"crossref","unstructured":"Su EJ, Lawrence DA (2022) Diabetes and the treatment of ischemic stroke. J Diabetes Complicat 108318","DOI":"10.1016\/j.jdiacomp.2022.108318"},{"issue":"12","key":"2804_CR258","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI200317977","volume":"111","author":"Y Sun","year":"2003","unstructured":"Sun Y et al (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Investig 111(12):1843\u20131851","journal-title":"J Clin Investig"},{"key":"2804_CR259","doi-asserted-by":"crossref","unstructured":"Sun MS, Jin H, Sun X, Huang S, Zhang FL, Guo ZN, Yang Y (2018) Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev 2018:3804979","DOI":"10.1155\/2018\/3804979"},{"issue":"1","key":"2804_CR260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-018-0135-7","volume":"7","author":"WR Swindell","year":"2018","unstructured":"Swindell WR et al (2018) GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis. Transl Neurodegener 7(1):1\u201324","journal-title":"Transl Neurodegener"},{"issue":"1","key":"2804_CR261","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.CIR.0000020682.73694.AB","volume":"106","author":"M Takemoto","year":"2002","unstructured":"Takemoto M et al (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106(1):57\u201362","journal-title":"Circulation"},{"issue":"15","key":"2804_CR262","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","volume":"41","author":"P Tanswell","year":"2002","unstructured":"Tanswell P et al (2002) Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin Pharmacokinet 41(15):1229\u20131245","journal-title":"Clin Pharmacokinet"},{"issue":"9171","key":"2804_CR263","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","volume":"353","author":"DW Taylor","year":"1999","unstructured":"Taylor DW et al (1999) Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. Lancet 353(9171):2179\u20132184","journal-title":"Lancet"},{"issue":"13","key":"2804_CR264","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.7150\/thno.56367","volume":"11","author":"T Tian","year":"2021","unstructured":"Tian T et al (2021) Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics 11(13):6507","journal-title":"Theranostics"},{"key":"2804_CR265","unstructured":"Tolliver A (n.d.) CE: Tenecteplase compared to alteplase for acute ischemic strokes"},{"issue":"1","key":"2804_CR266","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157016112798829760","volume":"10","author":"D Tousoulis","year":"2012","unstructured":"Tousoulis D et al (2012) The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10(1):4\u201318","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"2804_CR267","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","volume":"18","author":"K Toyoda","year":"2019","unstructured":"Toyoda K et al (2019) Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial. Lancet Neurol 18(6):539\u2013548","journal-title":"Lancet Neurol"},{"issue":"2","key":"2804_CR268","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1592\/phco.21.2.207.34103","volume":"21","author":"JP Tsikouris","year":"2001","unstructured":"Tsikouris JP, Tsikouris AP (2001) A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction. Pharmacotherapy: J Human Pharmacol Drug Therapy 21(2):207\u2013217","journal-title":"Pharmacotherapy: J Human Pharmacol Drug Therapy"},{"issue":"14","key":"2804_CR269","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2174\/156802609789869646","volume":"9","author":"A Tuttolomondo","year":"2009","unstructured":"Tuttolomondo A et al (2009) Neuron protection as a therapeutic target in acute ischemic stroke. Curr Top Med Chem 9(14):1317\u20131334","journal-title":"Curr Top Med Chem"},{"issue":"22","key":"2804_CR270","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.3390\/ijms222212585","volume":"22","author":"L Ugalde-Trivi\u00f1o","year":"2021","unstructured":"Ugalde-Trivi\u00f1o L, D\u00edaz-Guerra M (2021) PSD-95: an effective target for stroke therapy using neuroprotective peptides. Int J Mol Sci 22(22):12585","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2804_CR271","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","volume":"88","author":"PJ van der Most","year":"2009","unstructured":"van der Most PJ et al (2009) Statins: mechanisms of neuroprotection. Prog Neurobiol 88(1):64\u201375","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2804_CR272","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0002-9343(00)00380-6","volume":"109","author":"M Verstraete","year":"2000","unstructured":"Verstraete M (2000) Third-generation thrombolytic drugs. Am J Med 109(1):52\u201358","journal-title":"Am J Med"},{"key":"2804_CR273","doi-asserted-by":"crossref","unstructured":"Vukman KV et al (2017) Mast cell secretome: Soluble and vesicular components. Semin Cell Dev Biol 67:65\u201373","DOI":"10.1016\/j.semcdb.2017.02.002"},{"key":"2804_CR274","doi-asserted-by":"crossref","unstructured":"Walpoth BH, Daanen HA (2006) Immersion hypothermia. In: Handbook on Drowning. Springer, p. 481-531","DOI":"10.1007\/3-540-29656-5_9"},{"issue":"9","key":"2804_CR275","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1161\/STROKEAHA.112.658997","volume":"43","author":"Y Wang","year":"2012","unstructured":"Wang Y et al (2012) An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents. Stroke 43(9):2444\u20132449","journal-title":"Stroke"},{"issue":"3","key":"2804_CR276","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1007\/s12035-014-8952-x","volume":"52","author":"W Wang","year":"2015","unstructured":"Wang W et al (2015) Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers. Mol Neurobiol 52(3):1572\u20131579","journal-title":"Mol Neurobiol"},{"issue":"11","key":"2804_CR277","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1161\/STROKEAHA.120.029749","volume":"51","author":"SJ Warach","year":"2020","unstructured":"Warach SJ, Dula AN, Milling TJ Jr (2020) Tenecteplase thrombolysis for acute ischemic stroke. Stroke 51(11):3440\u20133451","journal-title":"Stroke"},{"key":"2804_CR278","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fneur.2018.00403","volume":"9","author":"Z Wei","year":"2018","unstructured":"Wei Z et al (2018) Therapeutic values of human urinary kallidinogenase on cerebrovascular diseases. Front Neurol 9:403","journal-title":"Front Neurol"},{"issue":"4","key":"2804_CR279","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01061694","volume":"5","author":"PG Welling","year":"1977","unstructured":"Welling PG (1977) Influence of food and diet on gastrointestinal drug absorption: a review. J Pharmacokinet Biopharm 5(4):291\u2013334","journal-title":"J Pharmacokinet Biopharm"},{"issue":"2","key":"2804_CR280","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s003950200000","volume":"97","author":"N Werner","year":"2002","unstructured":"Werner N, Nickenig G, Laufs U (2002) Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol 97(2):105\u2013116","journal-title":"Basic Res Cardiol"},{"issue":"1\u20132","key":"2804_CR281","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(00)00386-5","volume":"179","author":"BC White","year":"2000","unstructured":"White BC et al (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179(1\u20132):1\u201333","journal-title":"J Neurol Sci"},{"issue":"4","key":"2804_CR282","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/STROKEAHA.113.004362","volume":"45","author":"WN Whiteley","year":"2014","unstructured":"Whiteley WN et al (2014) Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial. Stroke 45(4):1000\u20131006","journal-title":"Stroke"},{"issue":"1","key":"2804_CR283","first-page":"13","volume":"22","author":"JT Willerson","year":"1995","unstructured":"Willerson JT (1995) Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. Tex Heart Inst J 22(1):13","journal-title":"Tex Heart Inst J"},{"issue":"27","key":"2804_CR284","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.2174\/138161212802430413","volume":"18","author":"PD Williams","year":"2012","unstructured":"Williams PD et al (2012) Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. Curr Pharm Des 18(27):4215\u20134222","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2804_CR285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-11","volume":"6","author":"TM Woodruff","year":"2011","unstructured":"Woodruff TM et al (2011) Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener 6(1):1\u201319","journal-title":"Mol Neurodegener"},{"issue":"8","key":"2804_CR286","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCRESAHA.121.319948","volume":"130","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Wakhloo AK, Fisher M (2022) Advances in acute ischemic stroke therapy. Circ Res 130(8):1230\u20131251","journal-title":"Circ Res"},{"issue":"10","key":"2804_CR287","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.biomaterials.2011.12.051","volume":"33","author":"S Yang","year":"2012","unstructured":"Yang S, Kim H-M (2012) The RhoA-ROCK-PTEN pathway as a molecular switch for anchorage dependent cell behavior. Biomaterials 33(10):2902\u20132915","journal-title":"Biomaterials"},{"issue":"4","key":"2804_CR288","first-page":"1","volume":"19","author":"JK Yang","year":"2017","unstructured":"Yang JK et al (2017) Interventional magnetic resonance imaging guided carotid embolectomy using a novel resonant marker catheter: demonstration of preclinical feasibility. Biomed Microdevice 19(4):1\u201311","journal-title":"Biomed Microdevice"},{"key":"2804_CR289","doi-asserted-by":"crossref","first-page":"116889","DOI":"10.1016\/j.lfs.2019.116889","volume":"236","author":"J-L Yang","year":"2019","unstructured":"Yang J-L, Yang Y-R, Chen S-D (2019) The potential of drug repurposing combined with reperfusion therapy in cerebral ischemic stroke: a supplementary strategy to endovascular thrombectomy. Life Sci 236:116889","journal-title":"Life Sci"},{"issue":"4","key":"2804_CR290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrn3174","volume":"13","author":"MA Yenari","year":"2012","unstructured":"Yenari MA, Han HS (2012) Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci 13(4):267\u2013278","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2804_CR291","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004647-200201000-00004","volume":"22","author":"MA Yenari","year":"2002","unstructured":"Yenari MA et al (2002) Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J Cereb Blood Flow Metab 22(1):29\u201338","journal-title":"J Cereb Blood Flow Metab"},{"key":"2804_CR292","unstructured":"Yeung PP et al (n.d.) Journal of Managed"},{"issue":"2","key":"2804_CR293","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5853\/jos.2017.00752","volume":"19","author":"AJ Yoo","year":"2017","unstructured":"Yoo AJ, Andersson T (2017) Thrombectomy in acute ischemic stroke: challenges to procedural success. J Stroke 19(2):121","journal-title":"J Stroke"},{"issue":"4","key":"2804_CR294","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-4159.2007.04866.x","volume":"103","author":"AR Young","year":"2007","unstructured":"Young AR et al (2007) Neuroprotection and stroke: time for a compromise. J Neurochem 103(4):1302\u20131309","journal-title":"J Neurochem"},{"issue":"9438","key":"2804_CR295","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet 364(9438):937\u2013952","journal-title":"The Lancet"},{"issue":"2","key":"2804_CR296","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","volume":"36","author":"N Zacharias-Millward","year":"2017","unstructured":"Zacharias-Millward N et al (2017) Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev 36(2):289\u2013303","journal-title":"Cancer Metastasis Rev"},{"key":"2804_CR297","doi-asserted-by":"crossref","first-page":"616590","DOI":"10.3389\/fcell.2020.616590","volume":"8","author":"J Zang","year":"2021","unstructured":"Zang J et al (2021) Inhibition of PDE1-B by vinpocetine regulates microglial exosomes and polarization through enhancing autophagic flux for neuroprotection against ischemic stroke. Front Cell Devel Biol 8:616590","journal-title":"Front Cell Devel Biol"},{"issue":"11","key":"2804_CR298","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3390\/diagnostics10110943","volume":"10","author":"M Zar\u00e0","year":"2020","unstructured":"Zar\u00e0 M et al (2020) Exosomes in Cardiovascular Diseases. Diagnostics 10(11):943","journal-title":"Diagnostics"},{"issue":"1","key":"2804_CR299","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1756-5391.2012.01167.x","volume":"5","author":"C Zhang","year":"2012","unstructured":"Zhang C et al (2012) Efficacy and safety of human urinary kallidinogenase injection for acute ischemic stroke: a systematic review. J Evid Based Med 5(1):31\u201339","journal-title":"J Evid Based Med"},{"key":"2804_CR300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neures.2017.09.002","volume":"131","author":"K Zhang","year":"2018","unstructured":"Zhang K et al (2018a) The Pyk2\/MCU pathway in the rat middle cerebral artery occlusion model of ischemic stroke. Neurosci Res 131:52\u201362","journal-title":"Neurosci Res"},{"key":"2804_CR301","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2017.11.041","volume":"819","author":"Y-S Zhang","year":"2018","unstructured":"Zhang Y-S, Li J-D, Yan C (2018b) An update on vinpocetine: new discoveries and clinical implications. Eur J Pharmacol 819:30\u201334","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"2804_CR302","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4252\/wjsc.v11.i10.817","volume":"11","author":"G-L Zhang","year":"2019","unstructured":"Zhang G-L, Zhu Z-H, Wang Y-Z (2019) Neural stem cell transplantation therapy for brain ischemic stroke: review and perspectives. World Journal of Stem Cells 11(10):817","journal-title":"World Journal of Stem Cells"},{"key":"2804_CR303","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2022.02.030","volume":"490","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang R, Wu J (2022) Inhibition of the NR2B\u2013PSD95 interaction exerts neuroprotective effects on retinal ischemia\u2013reperfusion injury. Neuroscience 490:89\u201399","journal-title":"Neuroscience"},{"issue":"4","key":"2804_CR304","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4103\/0028-3886.266274","volume":"67","author":"W Zhao","year":"2019","unstructured":"Zhao W, Xiao Z-J, Zhao S-P (2019) The benefits and risks of statin therapy in ischemic stroke: a review of the literature. Neurol India 67(4):983","journal-title":"Neurol India"},{"issue":"1","key":"2804_CR305","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jnc.15458","volume":"160","author":"J Zhou","year":"2022","unstructured":"Zhou J et al (2022) Fluid metabolic pathways after subarachnoid hemorrhage. J Neurochem 160(1):13\u201333","journal-title":"J Neurochem"},{"issue":"8","key":"2804_CR306","doi-asserted-by":"crossref","first-page":"1805452","DOI":"10.1002\/adma.201805452","volume":"31","author":"Y Zhu","year":"2019","unstructured":"Zhu Y et al (2019) Endovascular metal devices for the treatment of cerebrovascular diseases. Adv Mater 31(8):1805452","journal-title":"Adv Mater"},{"issue":"12","key":"2804_CR307","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci 12(12):723\u2013738","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"2804_CR308","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tins.2011.01.005","volume":"34","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV, Griffin JH (2011) Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci 34(4):198\u2013209","journal-title":"Trends Neurosci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02804-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:29:19Z","timestamp":1714991359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02804-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":308,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2804"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02804-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}